GTCR's Sterigenics agrees to buy Nordion for about $727 mln
Sterigenics, a portfolio company of U.S. private equity firm GTCR LLC, has agreed to acquire Nordion Inc (TSX:NDN) (NYSE:NDZ) for about US$727 million. According to the agreement, shareholders will receive $11.75 per share. Jefferies is advising Nordion on the transaction. Based in Ottawa, Nordion is a provider of products and services to the health science industry. Update: Upon closing of the deal, expected in the second half of 2014, Nordion will operate as a standalone company within Sterigenics and will continue to operate under its original name. GTCR bought Sterigenics, a Deerfield, Illinois-based provider of sterilization services, in 2011.
31 March 2014•7 mins read
